CTOs on the Move

Hunstman Expandable Polymers Co.

www.hunstman.com

 
Hunstman Expandable Polymers Co. is a High Point, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

INRAD

INRAD, Inc. is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. INRAD, Inc. is based in Northvale, NJ. You can find more information on INRAD, Inc. at www.inrad.com

Synthetic Biologics

Synthetic Biologics, Inc. trades on the NYSE MKT, LLC under the symbol "SYN". The Company`s principal executive offices are located in Rockville, MD, and the finance and administrative office is located in Ann Arbor, MI. Synthetic Biologics, Inc. is a microbiome-focused, clinical-stage company developing therapeutics to protect the microbiome while targeting pathogen-specific diseases. The Company`s lead candidates in Phase 2 development include SYN-004 which is designed to protect the gut microbiome from the effects of certain commonly used intravenous (IV) antibiotics for the prevention of C. difficile infection and antibiotic-associated diarrhea (AAD), and SYN-010 which is intended to reduce the impact of methane producing organisms in the gut microbiome to treat the underlying cause of irritable bowel syndrome with constipation (IBS-C). In addition, the Company is developing a monoclonal antibody combination for the treatment of Pertussis, and a Phase 2 oral estriol drug for the treatment of relapsing-remitting multiple sclerosis (MS) and cognitive dysfunction in MS.

Sentry BioPharma Services

Sentry BioPharma Services is a Indianapolis, IN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Lila Natural Cosmetics

Lila Natural Cosmetics is a Phoenix, AZ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

HealthiPASS

The healthcare landscape is ever-changing. Today, most patients face increasing health insurance deductibles resulting in high out-of-pocket costs. At the same time, providers struggle to collect patient responsibility for medical charges relying on standard collection methods - this is time consuming and can be expensive to the practice. The outcome can be costly causing lost revenue, increased collection costs, frustrated staff and patients.